Preparation and application of Fe-Gd double-mode magnetic resonance contrast agent with targeting function
A magnetic resonance contrast agent, dual-mode technology, applied in the direction of nuclear magnetic resonance/magnetic resonance imaging contrast agent, emulsion delivery, drug delivery, etc., can solve the problem of indistinguishable normal tissue from tumor tissue, contrast material entering tumor cells, Can not be fully detected and other problems, to achieve the effect of easy preparation method, uniform particle size, and good biocompatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Prepare silica-coated water-soluble iron ferric oxide nanoparticles with a large number of amino groups on the surface.
Embodiment 2
[0053] Preparation of ferroferric oxide magnetic nanoparticles linked with diethylenepentamineacetic acid DTPA ligand.
[0054] Take 20 mg of the silica-coated water-soluble iron ferric oxide nanoparticles prepared in Step Example 1 and dissolve them in 20 ml of anhydrous dimethylformamide; add 0.45 ml of triethylamine and 5 mg of diethylene Triaminepentaacetic acid dianhydride (diethylenetriaminepentaacetic acid dianhydride); magnetic stirring, the device was sealed and evacuated, under nitrogen protection; slowly heated to 80 degrees Celsius and stirred for 1 hour, and then allowed to stand at room temperature for 10 hours; 12000 rpm centrifugal separation, with 1 % triethylamine dimethylformamide washed twice, and then washed three times with ethanol to obtain ferric oxide nanoparticles linked with diethylenepentamineacetic acid ligands.
Embodiment 3
[0056] Preparation of ferroferric oxide magnetic nanoparticles linked with gadolinium diethylenepentamine acetate Gd-DTPA.
[0057] Get 20 milligrams of ferroferric oxide magnetic nanoparticles connected to the diethylenepentamineacetic acid DTPA ligand prepared in Example 2, and dissolve it in 10 milliliters of 0.05 mol / liter tris-hydrochloric acid Tris-HCl buffer solution In, add 5 or 20 mg gadolinium nitrate hexahydrate Gd (NO 3 ) 3 ×6H 2 O, magnetic stirring, heating in an oil bath at 35 degrees Celsius for more than 12 hours; centrifugation at 12,000 rpm for the reaction solution; washing with distilled water three times to obtain ferroferric oxide magnetic nanoparticles connected with gadolinium diethylenepentamine acetate, namely iron-gadolinium T 1 , T 2 The dual-mode magnetic resonance contrast agent has a molar ratio of gadolinium element to iron element of 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com